Private Portfolio Partners’s Novo Nordisk NVO Stock Holding History

Private Portfolio Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$390K	Buy	4,536 +73	+2%	+$7.89K	0.07%	202
2024 Q3	$531K	Buy	+4,463	New	+$595K	0.1%	159
2024 Q2	–	Sell	-4,448	Closed	-$571K	–	202
2024 Q1	$571K	Buy	4,448 +175	+4%	+$20.8K	0.12%	143
2023 Q4	$442K	Buy	4,273 +502	+13%	+$49.6K	0.1%	161
2023 Q3	$343K	Buy	3,771 +513	+16%	+$45.2K	0.09%	179
2023 Q2	$264K	Buy	+3,258	New	+$266K	0.07%	218

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Private Portfolio Partners's NVO Position: Q4 2024 in Review

Private Portfolio Partners increased its Novo Nordisk (NVO) stake by 1.6% in Q4 2024, buying an estimated $7.89K and bringing the position to 4,536 shares worth $390K. The position accounts for 0.07% of the portfolio, ranked #202.

Private Portfolio Partners first reported a position in NVO in Q2 2023 and has held it in 6 quarters since. The position peaked at $571K in Q1 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

Private Portfolio Partners held 4,536 shares of Novo Nordisk worth $390K as of Q4 2024.
Private Portfolio Partners bought 73 Novo Nordisk shares in Q4 2024, an estimated $7.89K.
Novo Nordisk made up 0.07% of Private Portfolio Partners's portfolio in Q4 2024, its #202 holding.
Private Portfolio Partners first reported a position in Novo Nordisk in Q2 2023 and has held it in 6 quarters since.
Private Portfolio Partners's Novo Nordisk position peaked at $571K in Q1 2024.
1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Private Portfolio Partners's 13F filing for Q4 2024, filed 12 Feb 2025.